Evidence map›Paper›PMID 35452744›Full record

ReviewNeuroscience and biobehavioral reviews2022

Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts.

Atul P Daiwile, Subramaniam Jayanthi, Jean Lud Cadet

Abstract readReview
In one paragraph

Review in Neuroscience and biobehavioral reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Atul P DaiwileMolecular Neuropsychiatry Research Branch, NIDA Intramural Research Program, Baltimore, MD 21224, USA. Electronic address: atul.daiwile@nih.gov.
Subramaniam JayanthiMolecular Neuropsychiatry Research Branch, NIDA Intramural Research Program, Baltimore, MD 21224, USA. Electronic address: sjayanth@intra.nida.nih.gov.
Jean Lud CadetMolecular Neuropsychiatry Research Branch, NIDA Intramural Research Program, Baltimore, MD 21224, USA. Electronic address: jcadet@intra.nida.nih.gov.

Funding

Neurotoxicity in the adult rat following chronic exposure to methamphetamineZIADA000552 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI CADET, JEAN LUD · 2009 to 2025
$34.3M
Intramural NIH HHS Z99 DA999999
6 · The paper itself

Abstract

Methamphetamine (METH) use, and misuse are associated with severe socioeconomic consequences. METH users develop tolerance, lose control over drug taking behaviors, and suffer frequent relapses even during treatment. The clinical course of METH use disorder is influenced by multifactorial METH-induced effects on the central and peripheral nervous systems. Although these METH-induced consequences are observed in humans of all ages, races, and sexes, sexual dimorphism in these outcomes have been observed in both pre-clinical and clinical settings. In this review, we have provided a detailed presentation of the sex differences reported in human and animal studies. We have therefore presented data that identified the influences of sex on METH pharmacokinetics, METH-induced changes in behaviors, cognitive processes, structural changes in the brain, and the effects of the drug on neurotransmitter systems and molecular mechanisms. Finally, we highlighted the potential significance of sex as a critical variable that should be considered when planning the development of new pharmacotherapeutic approaches against MEH use disorder in humans.

Indexed as

Central Nervous System StimulantsMethamphetamineAnimalsBrainFemaleHumansMaleSex CharacteristicsSexual BehaviorCentral Nervous System StimulantsMethamphetamineAdverse consequencesGeneticsMethamphetamineSex differencesTreatment

Identifiers

PMID35452744
PMCPMC9119944

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.